All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Implementing Change for Best Practices in Antimicrobial Stewardship

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) 

 View more SIDPEC Activities

Activity Description

Starting an antimicrobial stewardship program, or advancing an established one, can be a daunting task. This activity will provide an overview of tools for planning and implementing new and existing antimicrobial stewardship programs. This includes elements of strategic planning, self-assessment, and determining both long term and daily priorities. Examples of initiatives to achieve the Centers for Disease Control and Prevention’s Core Elements of Antimicrobial Stewardship Programs will be reviewed. The activity will also share tips for engaging team members and key stakeholders in the planning and implementation process.

This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on infectious disease pharmacotherapy for clinical pharmacists, health‐systems pharmacists, community pharmacists, and other allied‐health disciplines.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • List strategies for encouraging expansion of antimicrobial stewardship programs (ASPs) in healthcare systems
  • Describe how to perform an institutional self-assessment of ASP needs, strengths, and limitations
  • Explain how to prioritize program development objectives, metrics and timelines
  • Identify key administrators and resources to implement plans


Susan L. Davis, PharmD
Clinical Associate Professor of Pharmacy Practice
Wayne State University
Infectious Diseases Pharmacy Specialist
Henry Ford Health System
Detroit, Michigan


No commercial funding was received for this activity.

CE Accreditation

Release Date: 8-11-2017
Expiration Date: 8-11-2020


APCE This CE activity is jointly provided by ProCE, Inc. and SIDP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-153-H04-P has been assigned to this knowledge-based home-study CE activity (initial release date 8-11-2017). This CE activity is approved for 0.75 contact hour (0.075 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. CE credit will be uploaded to NABP/CPE Monitor. No partial credit will be given.


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed in this activity. Dr. Davis has served on advisory boards for Allergan, The Medicines Company, and Zavante.

Please note: The information and views presented in this activity are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include the use of drugs and/or devices for unlabeled indications, which should be considered experimental. Participants are advised to consult manufacturer product information and the professional literature, and use professional judgment in applying the presented information in patient-care activities.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Download Handout